Reply to: “Influence of ablation technique on treatment failure for perivascular hepatocellular carcinoma”

Preclinical studies of 166Ho-chitosan for treatment of hepatocellular carcinoma

Introduction: Recently, due to the special characteristics of 166Ho and chitosan, 166Ho-chitosan complex was developed for treatment of tumors such as hepatocellular carcinoma. This complex has been lately prepared with high radiochemical purity in our lab. The preclinical studies of the complex however should be performed to evaluate the tracer concentration in target and...

Radiofrequency Ablation for the Local Treatment of Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the 3 leading cause of cancer-related death worldwide, and the incidence of HCC is rising in the United States. Patients with cirrhosis of the liver and viral hepatitis are at the highest risk of developing HCC. Radiofrequency ablation has become an accepted first-line treatment for small HCC because of its similar outcomes when compared with surgical resection...

Thermal ablation of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is the fifth most common cause of cancer, and its incidence is increasing worldwide because of the dissemination of hepatitis B and C virus infection. Patients with cirrhosis are at the highest risk of developing HCC and should be monitored every 6 months to diagnose the tumour at an early, asymptomatic stage. Patients with early-stage HCC should be considered for...

Radiofrequency Ablation of Hepatocellular Carcinoma

Percutaneous Local Ablation Therapy for Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is a prevalent disease in Asia and the second leading cause of cancer death in Hong Kong.1 Surgical resection is regarded as the curative treatment. However, only 20% to 30% of HCC patients are suitable surgical candidates.2,3 Over the years, various locoregional therapies have been employed for the treatment of unresectable HCC. These include the widely practised...